| First Author | Giralt M | Year | 2002 |
| Journal | Exp Neurol | Volume | 173 |
| Issue | 1 | Pages | 114-28 |
| PubMed ID | 11771944 | Mgi Jnum | J:119136 |
| Mgi Id | MGI:3701365 | Doi | 10.1006/exnr.2001.7772 |
| Citation | Giralt M, et al. (2002) Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol 173(1):114-28 |
| abstractText | We have evaluated the physiological relevance of metallothionein-1+2 (MT-1+2) in the CNS following damage caused by a focal cryolesion onto the cortex. In comparison to normal mice, transgenic mice overexpressing the MT-1 isoform (TgMTI* mice) showed a significant decrease of the number of activated microglia/macrophage and of CD3+ T lymphocytes in the area surrounding the lesion, while astrocytosis was increased. The TgMTI* mice showed a diminished peripheral macrophage but not CD3 T cell response to the cryolesion. This altered inflammatory response produced a decreased expression of the proinflammatory cytokines IL-1beta, IL-6, and TNF-alpha and an increased expression of the growth factors bFGF, TGFbeta1, and VEGF in the TgMTI* mice relative to control mice, which might be related to the increased angiogenesis and regeneration of the parenchyma of the former mice. The overexpression of MT-1 dramatically reduced the cryolesion-induced oxidative stress and neuronal apoptosis. Remarkably, these effects were also obtained by the intraperitoneal administration of MT-2 to both normal and MT-1+2 knock-out mice. These results fully support the notion that MT-1+2 are essential in the CNS for coping with focal brain injury and suggest a potential therapeutic use of these proteins. |
